• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Age-related effects on thymic output and homeostatic T cell expansion following depletional induction in renal transplant recipients.肾移植受者耗竭诱导后胸腺输出和稳态 T 细胞扩增的年龄相关影响。
Am J Transplant. 2021 Sep;21(9):3163-3174. doi: 10.1111/ajt.16625. Epub 2021 May 20.
2
IL-7 receptor heterogeneity as a mechanism for repertoire change during postdepletional homeostatic proliferation and its relation to costimulation blockade-resistant rejection.IL-7 受体异质性作为耗竭后稳态增殖过程中库变化的机制及其与共刺激阻断耐药排斥反应的关系。
Am J Transplant. 2018 Mar;18(3):720-730. doi: 10.1111/ajt.14589. Epub 2017 Dec 12.
3
Postdepletion Lymphocyte Reconstitution During Belatacept and Rapamycin Treatment in Kidney Transplant Recipients.肾移植受者接受贝拉西普和雷帕霉素治疗期间的淋巴细胞消耗后重建
Am J Transplant. 2016 Feb;16(2):550-64. doi: 10.1111/ajt.13469. Epub 2015 Oct 5.
4
B cell reconstitution following alemtuzumab induction under a belatacept-based maintenance regimen.在基于贝利尤单抗的维持方案下使用阿仑单抗诱导后 B 细胞重建。
Am J Transplant. 2020 Mar;20(3):653-662. doi: 10.1111/ajt.15639. Epub 2019 Nov 13.
5
The number of circulating recent thymic emigrants is severely reduced 1 year after a single dose of alemtuzumab in renal transplant recipients.在接受单次阿仑单抗治疗后 1 年内,肾移植受者循环中的近期胸腺迁出细胞数量严重减少。
Transpl Int. 2010 Aug;23(8):786-95. doi: 10.1111/j.1432-2277.2010.01052.x. Epub 2010 Feb 3.
6
Rapamycin Prevents Expansion of Costimulation Blockade-resistant CD8+ Alloreactive Memory Cells following Depletional Induction in Renal Transplant Recipients.雷帕霉素预防肾移植受者耗竭诱导后共刺激阻断耐药 CD8+同种反应性记忆细胞的扩增。
J Immunol. 2024 Nov 1;213(9):1305-1317. doi: 10.4049/jimmunol.2400146.
7
Increased Pretransplant Frequency of CD28 CD4 T Predicts Belatacept-Resistant Rejection in Human Renal Transplant Recipients.移植前CD28阴性CD4 T细胞频率增加可预测人类肾移植受者对贝拉西普耐药的排斥反应。
Am J Transplant. 2017 Sep;17(9):2350-2362. doi: 10.1111/ajt.14350. Epub 2017 Jun 30.
8
Optimization of de novo belatacept-based immunosuppression administered to renal transplant recipients.优化肾移植受者应用贝那普利特的新免疫抑制方案。
Am J Transplant. 2021 May;21(5):1691-1698. doi: 10.1111/ajt.16386. Epub 2020 Nov 24.
9
Homeostatic repopulation by CD28-CD8+ T cells in alemtuzumab-depleted kidney transplant recipients treated with reduced immunosuppression.在接受免疫抑制降低治疗的阿仑单抗清除的肾移植受者中,CD28-CD8+ T细胞的稳态再填充。
Am J Transplant. 2008 Feb;8(2):338-47. doi: 10.1111/j.1600-6143.2007.02078.x.
10
Kinetics of homeostatic proliferation and thymopoiesis after rATG induction therapy in kidney transplant patients.肾移植患者接受 rATG 诱导治疗后,体内稳态增殖和胸腺生成的动力学变化。
Transplantation. 2013 Nov 27;96(10):904-13. doi: 10.1097/TP.0b013e3182a203e4.

引用本文的文献

1
Donor-specific mesenchymal stem cell infusion in human and nonhuman primate kidney transplantation.供体特异性间充质干细胞输注在人类和非人灵长类动物肾移植中的应用
Am J Transplant. 2025 May 12. doi: 10.1016/j.ajt.2025.05.008.
2
Exhaustion of CD8 central memory regulatory T cell differentiation is involved in renal allograft rejection.CD8 中枢记忆调节性 T 细胞分化耗竭参与肾移植排斥反应。
Front Immunol. 2025 Jan 24;16:1532086. doi: 10.3389/fimmu.2025.1532086. eCollection 2025.
3
Rapamycin Prevents Expansion of Costimulation Blockade-resistant CD8+ Alloreactive Memory Cells following Depletional Induction in Renal Transplant Recipients.雷帕霉素预防肾移植受者耗竭诱导后共刺激阻断耐药 CD8+同种反应性记忆细胞的扩增。
J Immunol. 2024 Nov 1;213(9):1305-1317. doi: 10.4049/jimmunol.2400146.

本文引用的文献

1
Kidney transplantation using alemtuzumab, belatacept, and sirolimus: Five-year follow-up.使用阿仑单抗、贝拉西普和西罗莫司的肾移植:五年随访
Am J Transplant. 2020 Dec;20(12):3609-3619. doi: 10.1111/ajt.16121. Epub 2020 Jun 30.
2
OPTN/SRTR 2018 Annual Data Report: Kidney.OPTN/SRTR 2018 年度数据报告:肾脏。
Am J Transplant. 2020 Jan;20 Suppl s1:20-130. doi: 10.1111/ajt.15672.
3
Human T Cell Development, Localization, and Function throughout Life.人类 T 细胞发育、定位和功能的终生变化。
Immunity. 2018 Feb 20;48(2):202-213. doi: 10.1016/j.immuni.2018.01.007.
4
IL-7 receptor heterogeneity as a mechanism for repertoire change during postdepletional homeostatic proliferation and its relation to costimulation blockade-resistant rejection.IL-7 受体异质性作为耗竭后稳态增殖过程中库变化的机制及其与共刺激阻断耐药排斥反应的关系。
Am J Transplant. 2018 Mar;18(3):720-730. doi: 10.1111/ajt.14589. Epub 2017 Dec 12.
5
CD4 T Cell Help via B Cells Is Required for Lymphopenia-Induced CD8 T Cell Proliferation.淋巴细胞减少诱导的CD8 T细胞增殖需要通过B细胞获得CD4 T细胞辅助。
J Immunol. 2016 Apr 1;196(7):3180-90. doi: 10.4049/jimmunol.1501435. Epub 2016 Feb 24.
6
CD57(+) CD4 T Cells Underlie Belatacept-Resistant Allograft Rejection.CD57(+) CD4 T细胞是贝拉西普抵抗性同种异体移植排斥反应的基础。
Am J Transplant. 2016 Apr;16(4):1102-12. doi: 10.1111/ajt.13613. Epub 2016 Jan 14.
7
Postdepletion Lymphocyte Reconstitution During Belatacept and Rapamycin Treatment in Kidney Transplant Recipients.肾移植受者接受贝拉西普和雷帕霉素治疗期间的淋巴细胞消耗后重建
Am J Transplant. 2016 Feb;16(2):550-64. doi: 10.1111/ajt.13469. Epub 2015 Oct 5.
8
Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors.使用贝拉西普进行肾移植,无需维持使用类固醇或钙调神经磷酸酶抑制剂。
Am J Transplant. 2014 May;14(5):1142-51. doi: 10.1111/ajt.12712. Epub 2014 Mar 31.
9
Recollective homeostasis and the immune consequences of peritransplant depletional induction therapy.回忆性稳态与移植前耗竭诱导疗法的免疫后果
Immunol Rev. 2014 Mar;258(1):167-82. doi: 10.1111/imr.12155.
10
The biology of recent thymic emigrants.近期胸腺迁出细胞的生物学。
Annu Rev Immunol. 2013;31:31-50. doi: 10.1146/annurev-immunol-032712-100010. Epub 2012 Nov 1.

肾移植受者耗竭诱导后胸腺输出和稳态 T 细胞扩增的年龄相关影响。

Age-related effects on thymic output and homeostatic T cell expansion following depletional induction in renal transplant recipients.

机构信息

Department of Surgery, Duke Transplant Center, Duke University School of Medicine, Durham, North Carolina, USA.

Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina, USA.

出版信息

Am J Transplant. 2021 Sep;21(9):3163-3174. doi: 10.1111/ajt.16625. Epub 2021 May 20.

DOI:10.1111/ajt.16625
PMID:33942491
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8429231/
Abstract

Thymic output and homeostatic mature cell proliferation both influence T cell repopulation following depletional induction, though the relative contribution of each and their association with recipient age have not been well studied. We investigated the repopulating T cell kinetics in kidney transplant recipients who underwent alemtuzumab induction followed by belatacept/rapamycin-based immunosuppression over 36-month posttransplantation. We focused specifically on the correlation between repopulating T cell subsets and the age of patients. Substantial homeostatic Ki67-expressing T cell proliferation was seen posttransplantation. A repertoire enriched for naïve T (T ) cells emerged posttransplantation. Analysis by generalized estimating equation linear models revealed a strong negative linear association between reconstituting T cells and advancing age. A relationship between age and persistence of effector memory cells was shown. We assessed thymic output and found an increase in the frequency of recent thymic emigrants (RTEs, CD4 CD31 ) at 12-month posttransplantation. Patients under 30 years of age showed significantly higher levels of CD4 CD31 cells than patients over 55 years of age pre- and posttransplantation. IL-7 and autologous mature dendritic cells (mDCs) induced CD57 cell proliferation. In contrast, mDCs, but not IL-7, induced CD57 cell proliferation. This study establishes the relationship between age and thymic output during T cell homeostatic repopulation after alemtuzumab induction. Trial Registration: ClinicalTrials.gov - NCT00565773.

摘要

胸腺输出和稳态成熟细胞增殖都会影响耗竭诱导后的 T 细胞再定居,但它们的相对贡献及其与受者年龄的关系尚未得到很好的研究。我们研究了接受阿仑单抗诱导后接受贝利木单抗/雷帕霉素免疫抑制治疗的肾移植受者在移植后 36 个月内的 T 细胞再定居动力学。我们特别关注 T 细胞再定居亚群与患者年龄之间的相关性。移植后观察到大量的稳态 Ki67 表达 T 细胞增殖。移植后出现了富含幼稚 T(T)细胞的库。广义估计方程线性模型分析显示,再定居 T 细胞与年龄增长呈强烈负线性相关。还显示了年龄与效应记忆细胞持续存在之间的关系。我们评估了胸腺输出,发现移植后 12 个月时近期胸腺迁出细胞(RTEs,CD4 CD31)的频率增加。<30 岁的患者在移植前和移植后均显著高于>55 岁的患者。IL-7 和自体成熟树突状细胞(mDC)诱导 CD57 细胞增殖。相比之下,mDC 而不是 IL-7 诱导 CD57 细胞增殖。这项研究确立了阿仑单抗诱导后 T 细胞稳态再定居期间年龄与胸腺输出之间的关系。

试验注册

ClinicalTrials.gov - NCT00565773。